TELA Bio, Inc.

For the period ended Dec 31, 2024. Filed Mar 21, 2025.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 21, 2025

TELA$0.80-7.5%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Operations and Comprehensive Loss

(In thousands, except share and per share amounts)


· · Year ended December 31,
· 2024 · · 2023 · 2022
Revenue	$69,300	$58,453	$41,418
Cost of revenue (excluding amortization of intangible assets)	22,432	17,961	13,570
Amortization of intangible assets	380	380	804
Gross profit	46,488	40,112	27,044
Operating expenses:
Sales and marketing	64,648	59,681	43,252
General and administrative	14,722	14,887	13,862
Research and development	8,813	9,619	8,937
Total operating expenses	88,183	84,187	66,051
Other operating income:
Gain on sale of product line	7,580	—	—
Loss from operations	(34,115)	(44,075)	(39,007)
Other (expense) income:
Interest expense	(5,290)	(5,223)	(4,051)
Loss on extinguishment of debt	—	—	(1,228)
Other income	1,420	2,634	(10)
Total other expense, net	(3,870)	(2,589)	(5,289)
Loss before income tax benefit	$(37,985)	$(46,664)	$(44,296)
Income tax benefit	144	—	—
Net loss	(37,841)	(46,664)	(44,296)
Net loss per common share, basic and diluted	$(1.33)	$(2.04)	$(2.72)
Weighted average common shares outstanding, basic and diluted	28,526,441	22,868,663	16,267,678
Comprehensive loss:
Net loss	$(37,841)	$(46,664)	$(44,296)
Foreign currency translation adjustment	(1)	(59)	202
Comprehensive loss	$(37,842)	$(46,723)	$(44,094)

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.